Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
about
In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release.Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory ResponsesUncovering the Catalytic Direction of Chondroitin AC Exolyase: FROM THE REDUCING END TOWARDS THE NON-REDUCING ENDThe design and synthesis of new synthetic low-molecular-weight heparins.Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties.Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.De novo synthesis of a narrow size distribution low-molecular-weight heparin.Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.New Applications of Heparin and Other Glycosaminoglycans.Anticoagulation in renal failure is safe and effective.Structural Characterization of the Low-Molecular-Weight Heparin Dalteparin by Combining Different Analytical Strategies.Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells.
P2860
Q33894433-752EFB88-AE35-43B3-A60F-1AE16C0ED0B3Q35719599-C7DABC32-D660-4407-B827-08E61953B393Q36744482-9147E13B-84DB-4541-959A-E6E4923A9E57Q37004231-716C6755-461D-4066-9742-4E8A4ABF0AA8Q37151014-54F78746-81CF-4233-A577-B0C412DACE57Q37586232-8A4B5FD4-0242-4924-B644-A22C2579B29DQ37685686-02FA84AB-59D0-4E27-8CC8-1E157072608EQ38127447-0F98849D-9649-40C7-A196-A8DD4C828061Q38319635-5EE214E0-671D-4AF5-9C58-09209D302B5EQ39290481-967121E1-B78F-46CF-8EC4-FA888CA1F52EQ42690754-115B2E81-04DA-41E6-966D-68FCEED87CC0Q47202574-EB8183E6-4E21-4B0F-8C11-A8AB12807037Q47327922-3DC2D05A-E31E-478A-9C89-34473B7DFB6E
P2860
Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Structural features of low-mol ...... heir affinity to antithrombin.
@en
Structural features of low-mol ...... heir affinity to antithrombin.
@nl
type
label
Structural features of low-mol ...... heir affinity to antithrombin.
@en
Structural features of low-mol ...... heir affinity to antithrombin.
@nl
prefLabel
Structural features of low-mol ...... heir affinity to antithrombin.
@en
Structural features of low-mol ...... heir affinity to antithrombin.
@nl
P2093
P356
P1476
Structural features of low-mol ...... heir affinity to antithrombin.
@en
P2093
Annamaria Naggi
Antonella Bisio
Davide Vecchietti
Giangiacomo Torri
Giorgio Eisele
Laura Citterio
Rahul Raman
Ram Sasisekharan
Sabrina Bertini
P304
P356
10.1160/TH09-02-0081
P577
2009-11-01T00:00:00Z